Targeting Tumor Antigens to Secreted Membrane VesiclesIn vivoInduces Efficient Antitumor Immune Responses
Authors:
- Matias OstrowskiMOMatias Ostrowski
- Alexandre BoissonnasABAlexandre Boissonnas
- Sebastian AmigorenaSASebastian Amigorena
- Clotilde ThérYCTClotilde ThérY
- Béhazine CombadièreBCBéhazine Combadière
- 15 February 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (4) , 1228-1235
Abstract
Expression of non-self antigens by tumors can induce activation of T cells in vivo, although this activation can lead to either immunity or tolerance. CD8+ T-cell activation can be direct (if the tumor expresses MHC class I molecules) or indirect (after the capture and cross-presentation of tumor antigens by dendritic cells). The modes of tumor antigen capture by dendritic cells in vivo remain unclear. Here we examine the immunogenicity of the same model antigen secreted by live tumors either in association with membrane vesicles (exosomes) or as a soluble protein. We have artificially addressed the antigen to secreted vesicles by coupling it to the factor VIII–like C1C2 domain of milk fat globule epidermal growth factor-factor VIII (MFG-E8)/lactadherin. We show that murine fibrosarcoma tumor cells that secrete vesicle-bound antigen grow slower than tumors that secrete soluble antigen in immunocompetent, but not in immunodeficient, host mice. This growth difference is due to the induction of a more potent antigen-specific antitumor immune response in vivo by the vesicle-bound than by the soluble antigen. Finally, in vivo secretion of the vesicle-bound antigen either by tumors or by vaccination with naked DNA protects against soluble antigen-secreting tumors. We conclude that the mode of secretion can determine the immunogenicity of tumor antigens and that manipulation of the mode of antigen secretion may be used to optimize antitumor vaccination protocols. [Cancer Res 2008;68(4):1228–35]Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified CytokinesJournal of Virology, 2007
- Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell deathCytometry Part A, 2006
- Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T LymphocytesCancer Research, 2006
- DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvantVaccine, 2005
- Lactadherin binds selectively to membranes containing phosphatidyl-l-serine and increased curvatureBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Principles of tumor immunosurveillance and implications for immunotherapyCancer Gene Therapy, 2002
- The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In VivoJournal of Experimental Medicine, 2002
- Identification of a factor that links apoptotic cells to phagocytesNature, 2002
- Functional Analyses of Two Cellular Binding Domains of Bovine LactadherinBiochemistry, 2000
- A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.Journal of Experimental Medicine, 1992